Pediatric Psychopharmacology: Mood Disorders
Presented live at the 7th Annual Clinical Psychopharmacology Institute in June 2009, Dr. Julie Carbray speaks on prescribing for children with mood disorders.
Julie A. Carbray, PhD, APN, PMHCNS-BC
Clinical Associate Professor of Nursing and Psychiatry; Administrative Director, Pediatric Mood Disorder Clinic
Disclosures: AstraZeneca Pharmaceuticals
There will be discussion of off-label use of a drug or product in this presentation. The activity planners have no conflicts of interest to disclose.
Upon completion of this presentation, the participant will be able to:
1. Relate underlying brain circuitry dysfunction underpinning Pediatric Bipolar Disorder.
2. Understand and use several strategies and tactics for the successful pharmacologic treatment of children and adolescents with pediatric bipolar disorder.
3. Identify which mood stabilizers and atypical agents have the strongest evidence base for use in children and agents.
4. Discuss the side effect and adverse profile of mood stabilizers and atypical antipsychotics used to treat bipolar disorder in children and adolescents.
Continuing Nursing Education
1.5 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to earn a score of 80% or better on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centerís Commission on Accreditation.
June 26, 2009
1:30 - 3:00pm
Hyatt Regency Reston
Release Date: September 1, 2009
The contact hours for this session expire: September 1, 2011